Literature DB >> 27286633

Ternary inclusion complex formation and stabilization of limaprost, a prostaglandin E1 derivative, in the presence of α- and β-cyclodextrins in the solid state.

Yasuo Inoue1, Daisuke Iohara2, Noboru Sekiya3, Masanobu Yamamoto4, Hiroyuki Ishida5, Yoko Sakiyama5, Fumitoshi Hirayama2, Hidetoshi Arima6, Kaneto Uekama2.   

Abstract

Limaprost/α-cyclodextrin (CD)/β-CD ternary inclusion complex was prepared by freeze-drying a solution containing all three components. Under humid conditions, limaprost was more stable in the ternary α-/β-CD inclusion complex than in the binary α- or β-CD complex. Specifically, during storage at 30°C/75% relative humidity (R.H.) for 4 weeks, about 19% of limaprost degraded into 17S,20-dimethyl-trans-Δ(2)-prostaglandin A1 (referred as 11-deoxy-Δ(10)) in the β-CD complex, 8.1% degraded in the α-CD complex, and only 2.2% degraded in the α-/β-CD complex. The mechanism of limaprost stabilization in the presence of both CDs was investigated by Raman and solid-state NMR spectroscopy and powder X-ray diffractometry. The fast degradation of limaprost to 11-deoxy-Δ(10) in the β-CD complex was due to the rapid crystallization of β-CD from the complex, liberating the free amorphous drug, which is susceptible to degradation. The dissociation and crystallization of β-CD from the inclusion complex were suppressed by freeze-drying limaprost in the presence of both α- and β-CDs. In addition, the interaction between limaprost and the two CDs was reinforced by inclusion of different moieties of limaprost: α-CD predominantly included the alkyl ω-chain, whereas β-CD included the five-membered ring. Thus, a stable ternary inclusion complex was formed that included limaprost, maintaining the amorphous state of the complex and dramatically stabilizing the drug under humid conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyclodextrin; Limaprost; Solid state; Stability; Ternary inclusion complex

Mesh:

Substances:

Year:  2016        PMID: 27286633     DOI: 10.1016/j.ijpharm.2016.06.018

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.

Authors:  Tomoya Hayashi; Masatoshi Momota; Etsushi Kuroda; Takato Kusakabe; Shingo Kobari; Kotaro Makisaka; Yoshitaka Ohno; Yusuke Suzuki; Fumika Nakagawa; Michelle S J Lee; Cevayir Coban; Risako Onodera; Taishi Higashi; Keiichi Motoyama; Ken J Ishii; Hidetoshi Arima
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

2.  Effect of antioxidant activity of caffeic acid with cyclodextrins using ground mixture method.

Authors:  Ryota Shiozawa; Yutaka Inoue; Isamu Murata; Ikuo Kanamoto
Journal:  Asian J Pharm Sci       Date:  2017-10-14       Impact factor: 6.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.